UNSPSC 51351622: Estradiol cypionate

This classification denotes a therapeutic estradiol, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7E1DV054LO. European Medicines Agency schedules Estradiol cipionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01965MIG. Estradiol cypionate generally arises in the molecular formula C26H36O3. The term 'estradiol cypionate' is a U.S. Pharmacopeial Convention designation. Most nations, for tariff and trade purposes, schedule estradiol cypionate under HS 29372300.

As of Q4 2014, ESTRADIOL CYPIONATE remains US FDA's Preferred Term for this commodity. Estradiol cypionate bears US NLM identifiers UMLS ID C0059610 and NCI Concept Code C47991. SMILES: C[C@]12CC[C@@H]3C4CCC(CC4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC5CCCC5)O.

UNSPSC 51351622 Estradiol cypionate is a Commodity code covering a synthetic estrogen pharmaceutical used in hormone replacement therapy and veterinary applications. State and local governments procure this pharmaceutical primarily through health department acquisitions, correctional health services, and animal control or veterinary programs operated by counties and municipalities. The drug is typically sourced as a sterile injectable formulation and purchased through established pharmaceutical supply contracts or cooperative purchasing vehicles that aggregate demand across jurisdictions.

The source material provides no recent state or local solicitations or opportunities under this code, limiting visibility into current geographic concentration, issuing-body patterns, or representative procurement activity at the state, county, or municipal level.